5 July 2019

1 year of Oncode: building the Launching Platform

Public summary of the Oncode Annual Report 2018

Elize Brolsma

Oncode is proud to present the public summary of its first Annual Report, which showcases highlights of the first year of Oncode. We invite you to read about how we set out to build the foundations of our Research Institute. An institute which fosters a multidisciplinary research environment. Where researchers are provided with access to world class infrastructure, technologies, training, support teams and the financial means to support high-risk research projects. In 2018 we focused on building the launching platform for our future activities. We launched key scientific programmes, started up a dedicated valorization team, hosted events, built an online community and shaped a dedicated patient engagement programme.

In short, the report shows you the many ways we are working on our mission: outsmarting cancer, impacting lives.

The Oncode Management Board 

Click here to read the full report

Other News

Oncode Coverbeeld Q2 2021
Oncode Digital Magazine - April 2021
Welcome to the April edition of our digital magazine! Discover the latest interviews, science stories, latest updates and much more.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Lude and Michiel
Oncode Investigators Michiel Vermeulen and Lude Franke receive Vici grant
Oncode is proud to announce that Oncode Investigators Michiel Vermeulen (Radboudumc) and Lude Franke (UMCG) will both receive the Vici grant of 1.5 million euros from the Dutch Research Council (NWO).
PeterThijssen
Ecto org KRT14
First patient-derived organoid model for cervical cancer
Researchers from the group of Oncode Investigator Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In close collaboration with the UMC Utrecht, Princess Máxima Center for pediatric oncology and the Netherlands Cancer Institute, the researchers used the organoid-based platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study the human papillomavirus (HPV), which is one of the main causes of cervical cancer.
Bianca-OliviaNita